Senate Confirms New Head of FDA: Two-Time ExL Speaker Dr. Scott Gottlieb
Monday May 15th, 2017
ExL Events would like to congratulate our speaker alumnus Dr. Scott Gottlieb for the recent United States Senate confirmation, naming him the new Food and Drug Administration commissioner. Dr. Gottlieb was the keynote speaker at ExL’s 2nd Trial Design Innovation Conference and was also a featured speaker at our Private Fee-for-Service event.
President Donald Trump nominated Gottlieb earlier this year, for his previous service as deputy commissioner for the FDA, as well as his experience in the pharmaceutical and health care industries. As the FDA’s newly appointed commissioner, Gottlieb will take on regulations concerning product and safety approvals of prescription drugs and medical devices, as well as tobacco, food, and cosmetics.
In his Senate confirmation hearing last month, Gottlieb addressed heavy-hitting topics such as the misuse of opioids, reducing the prices of drugs, vaccine safety and more. As a result of this hearing and his background as a healthcare professional, he was voted in as the agency’s new head by a 57 to 42 margin in the Senate on Tuesday, May 10, 2017.
For a good taste of what to expect from the newly appointed FDA commissioner, head over to his official Forbes blog, in-which he discusses policy, public health and regulations issues.
— Scott Gottlieb, MD (@ScottGottliebMD) May 10, 2017
The Senate Majority Leader appointed Dr. Gottlieb to serve on the Federal Health Information Technology Policy Committee in 2013, and also served as Board Director to CombiMatrix (CMBX); MedaVante; American Pathology Partners; and Aptiv Solutions before this confirmation. He was also the Clinical Assistant Professor at the New York University School of Medicine in Manhattan.
You can learn more about our new FDA commissioner by checking out his official biography right here.